A new generation of bradykinin antagonists

Immunopharmacology

Volumn 33, Issue 1-3, 1996, Pages 51-60

  Stewart, John M ^a   Gera, Lajos ^a   Hanson, Wendy ^b   Zuzack, John S ^b   Burkard, Mike ^b   McCullough, Rosann ^b   Whalley, Eric T ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Departments of New Leads Chemistry and Pharmacology   (United States)

Author keywords

blood pressure; bradykinin; bradykinin antagonist; bradykinin receptor

Indexed keywords

ACETYLCHOLINE; ALPHA (2 INDANYL)GLYCINE; ANGIOTENSIN; B 9430; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ[1-8]; ICATIBANT; KININASE; NORADRENALIN; SUBSTANCE P; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FEMALE; GUINEA PIG; HUMAN; HYPERALGESIA; ILEUM; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PAW EDEMA; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS;

EID: 0030175967     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00084-7     Document Type: Conference Paper

References (37)

1. Arunlakshana O, Schild HO: Some quantitative uses of drug antagonists. Br J Pharmacol 1959; 14: 48-58.
2. Booth and Kenny. A rapid method for the preparation of microvilli from rabbit kidney. Biochem J 1974; 142: 575-581.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
4. 2 receptors. Immunopharmacology 33, in press.
5. Cheronis JC, Whalley ET, Nguyen KT, Eubanks SR, Allen LG, Duggan MJ, Loy SD, Bonham KA, Blodgett JK. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers. J Med Chem 1992; 35: 1563-1572.
6. 2 antagonist activity. J Med Chem 1994; 37: 348-355.
7. 1 receptor antagonist activity. J Med Chem 1996; 39: 1472-1484.
8. Hanson WL, McCullough R, Selig WM, Wieczorek M, Ross S, Whalley ET, Stewart JM, Gera L. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors. Immunopharmacology 33, in press.
9. Hill JT, Dunn FW. Preparation and resolution of cyclopentaneglycine. J Org Chem 1969; 30: 1321-1322.
10. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke St. Breipohl G, König W, Schölkens BA. HOE-140, a new, potent and long acting bradykinin antagonist: in vitro studies. Br J Pharmacol 1991; 102: 769-773.
11. Kyle DJ, Martin JA, Burch RM, Carter JP, Lu S, Meeker S, Prosser JC, Sullivan JP, Togo J, Noronha-Blob L, Sinsko JA, Walters RF, Whaley LW, Hiner RN. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides. J Med Chem 1991; 34: 2649-2653.
12. Kyle DJ, Blake PR, Smithwick D, Green LM, Martin JA, Sinsko JA, Summers MF. NMR and computational evidence that high affinity bradykinin receptor antagonists adopt C-terminal β-turns. J Med Chem 1993; 36: 1450-1460.
13. Lembeck F, Griesbacher T, Eckhardt M, Henke S, Breipohl G, Knolle J: New, long-acting, potent bradykinin antagonists. Br J Pharmacol 1991; 102: 297-304.
14. 1 receptors: a review. Immunopharmacology 1995; 30: 1-26.
15. Marceau F, Barabé J, St-Pierre S, Regoli D: Kinin receptors in experimental inflammation. Can J Physiol Pharmacol 1980; 58: 536-542.
16. Marceau F, Lussier A, Regoli D, Giroud JP: Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol 1983; 14: 209-229.
17. 9-Bradykinin by bacterial endotoxin. Pharmacology 1984; 29: 70-74.
18. 1 receptors in vivo in a model of untra-violet irradiation-induced thermal hyperalgesia in the rat. Br J Pharmacol 1993; 110: 1441-1444.
19. 8]-BK and HOE-140, in two models of persistent hyperalgesia in the rat. Pain 1993; 53: 191-197.
20. Porter TH, Shive W, DL-2-Indaneglycine and DL-β-trimethylsilylalanine. J Med Chem 1968; 11: 402-403.
21. Regoli D, Barabé J: Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46.
22. Regoli D, Barabé J, Park WK. Receptors for bradykinin in rabbit aorta. Can J Physiol Pharmacol 1977; 55: 855-867.
23. 2 receptor systems. Eur J Pharmacol 1986a; 123: 61-66.
24. 1 receptor activators and blockers in isolated vessels. Eur J Pharmacol 1986b; 127: 219-224.
25. Roblero J, Ryan JW, Stewart JM. Assay of kinins by their efcet on blood pressure. Res Commun Chem Pathol 1973; 6: 207-212.
26. 9-bradykinin increases during E. coli septicemia in the pig. Adv Exp Med Biol 1989; 247B: 389-393.
27. Skidgel, R, Johnson A, Erdos E. Hydrolysis of opioid hexapeptides by Carboxypeptidase N. Biochem Pharmacol 1984; 33: 3471-3478.
28. Stewart, J.M. Roles for kinins in inflammation. In Mediators of the inflammatory process. Henson PM, Murphy RC, Eds. Elsevier, Amsterdam, 1989: 189-217.
29. 2 bradykinin antagonists. In Bradykinin Antagonists. Burch RM, Ed. Pergamon, Oxford, 1991; 51-96.
30. Stewart JM, Young JD. Solid Phase Peptide Synthesis. Rockford, IL: Pierce Chemical Co., 1984.
31. Togo J, Burch RM, DeHaas J, Connor JR, Steranka LR. D-Phe? substituted peptide bradykinin antagonists are not substrates for kininase II. Peptides 1989; 10: 109-112.
32. Vavrek RJ, Stewart JM. Competitive antagonists of bradykinin. Peptides 1985; 6: 161-164.
33. Vavrek RJ, Gera L, Stewart JM. Bradykinin antagonists do not require a D-aromatic amino acid residue at position seven. Agents Actions 1992; 38SI: 572-581.
34. 2 kinin receptors in cultured bovine aortic endothelial cells. J Pharmacol Exp Ther 1992; 262(2): 729-733.
35. 1 receptor antagonist. Eur J Pharmacol 1991a; 205: 217-218.
36. Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henke S, Breipohl G, Konig W, Knolle J, Scholkens BA: Hoe 140 a new potent and long acting bradykinin antagonist - in vivo studies. Br J Pharmacol 1991b; 102: 774-777.
37. Zuzack JS, Burkard MR, Cuadrado DK, Greer RA, Selig WM, and Whalley ET. Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor. J Pharmacol Exp Ther 1996, in press.